Abir Azri | Molecular Biology | Best Researcher Award Published on 19/09/202519/09/2025 by World Top Scientists Ms. Abir Azri | Molecular Biology | Best Researcher Award Abir Azri | Higher Institute of Biotechnology of Monastir | Tunisia Ms. Abir Azri is a dedicated PhD candidate in Biological Sciences and Biotechnology with a strong background in molecular biology, bioinformatics, and genetics. Her research focuses on human genetic polymorphisms and their association with the severity of COVID-19, addressing critical questions in health and disease susceptibility. She has gained diverse international research experience through advanced training and laboratory work in genomics, oncology, virology, and molecular medicine across Tunisia, Spain, and Italy. Ms. Azri has actively contributed to scientific conferences, presenting her findings on DNA methylation and genetic risk factors, and has co-authored research outputs in collaborative projects. Her technical expertise spans bioinformatics tools, molecular biology techniques, and statistical analysis, making her highly versatile in both computational and experimental research. With her passion for discovery, strong academic preparation, and global exposure, she demonstrates significant potential to advance biomedical research and contribute meaningfully to addressing complex health challenges. Profile: ORCID Featured Publications 1. L. Maddaloni, G. Bugani, M. Fracella, C. Bitossi, A. D’Auria, F. Aloisi, A. Azri, L. Santinelli, M. B. M’Hadheb, A. Pierangeli, et al., “Pattern Recognition Receptors (PRRs) Expression and Activation in COVID-19 and Long COVID: From SARS-CoV-2 Escape Mechanisms to Emerging PRR-Targeted Immunotherapies,” Microorganisms, vol. 13, no. 9, p. 2176, Sep. 2025. 2. O. Castellini-Pérez, E. Povedano-Espejo, G. Barturen, A. Azri, R. Dominguez, M. E. Alarcón-Riquelme, and E. Carnero-Montoro, “Exploring the impact of genome-wide DNA methylation alterations on chromosome X inactivation and female lupus,” in Proc. Lupus 2024 Conf., Mar. 2024, p. O5.
Ms. Abir Azri is a dedicated PhD candidate in Biological Sciences and Biotechnology with a strong background in molecular biology, bioinformatics, and genetics. Her research focuses on human genetic polymorphisms and their association with the severity of COVID-19, addressing critical questions in health and disease susceptibility. She has gained diverse international research experience through advanced training and laboratory work in genomics, oncology, virology, and molecular medicine across Tunisia, Spain, and Italy. Ms. Azri has actively contributed to scientific conferences, presenting her findings on DNA methylation and genetic risk factors, and has co-authored research outputs in collaborative projects. Her technical expertise spans bioinformatics tools, molecular biology techniques, and statistical analysis, making her highly versatile in both computational and experimental research. With her passion for discovery, strong academic preparation, and global exposure, she demonstrates significant potential to advance biomedical research and contribute meaningfully to addressing complex health challenges. Profile: ORCID Featured Publications 1. L. Maddaloni, G. Bugani, M. Fracella, C. Bitossi, A. D’Auria, F. Aloisi, A. Azri, L. Santinelli, M. B. M’Hadheb, A. Pierangeli, et al., “Pattern Recognition Receptors (PRRs) Expression and Activation in COVID-19 and Long COVID: From SARS-CoV-2 Escape Mechanisms to Emerging PRR-Targeted Immunotherapies,” Microorganisms, vol. 13, no. 9, p. 2176, Sep. 2025. 2. O. Castellini-Pérez, E. Povedano-Espejo, G. Barturen, A. Azri, R. Dominguez, M. E. Alarcón-Riquelme, and E. Carnero-Montoro, “Exploring the impact of genome-wide DNA methylation alterations on chromosome X inactivation and female lupus,” in Proc. Lupus 2024 Conf., Mar. 2024, p. O5.